Page 101 - TD-3-3
P. 101

Tumor Discovery





                                        ORIGINAL RESEARCH ARTICLE
                                        Evaluating the effectiveness of artificial

                                        intelligence imaging in the qualitative diagnosis
                                        of pulmonary nodules



                                        Chunlan Hu 1  , Dan Yang 1  , Xiangwen Luo 1  , Chao Lv 1  , Juan Li 1  ,
                                                                                   2
                                        Yaya Zhang 1  , Xinrong Xiong 1  , and Long Zhou *
                                        1 Cancer Early Diagnosis and  Treatment Center, Clinical Research Center, Medical Pathology
                                        Center, and Translational Medicine Research Center, Chongqing University Three Gorges Hospital,
                                        Chongqing University, Chongqing, China
                                        2 Department of Laboratory Medicine, Chongqing University  Three Gorges Hospital, Chongqing
                                        University, Chongqing, China
                                        (This article belongs to the Special Issue: New Developments in Lung Cancer Research, Diagnosis,
                                        Treatment, and Prognosis)



                                        Abstract

                                        Our study aimed to evaluate the effectiveness of artificial intelligence (AI) image
                                        diagnostic systems in the qualitative diagnosis of pulmonary nodules. We analyzed
                                        291 cases from June 2023 to January 2024 at Chongqing University Three Gorges
                                        Hospital. All patients in the study underwent low-dose chest computed tomography
                                        scans, which identified lung nodules, followed by thoracic surgery for pathological
                                        confirmation.  We compared the predictive accuracy of AI-based diagnosis with
                                        that of physician-based diagnosis in distinguishing between benign and malignant
            *Corresponding author:
            Long Zhou                   lung nodules. Among the 291 lung nodules examined, 226 were cancerous, and 65
            (goldfall2004@163.com)      were benign. Receiver operating characteristic (ROC) curves, plotted based on the
                                        malignancy probabilities predicted by both methods, revealed that the AI group
            Citation: Hu C, Yang D, Luo X,
            et  al. Evaluating the effectiveness   achieved an area under the ROC curve (AUC) of 0.727, with a sensitivity of 90.27% and
            of artificial intelligence imaging   a specificity of 58.46%. In comparison, the physician-reading group had an AUC of
            in the qualitative diagnosis of   0.737, with a sensitivity of 83.19% and a specificity of 66.15%. Our findings demonstrate
            pulmonary nodules. Tumor Discov.
            2024;3(3):4718.             that the AI diagnostic system effectively calculates malignancy probabilities for lung
            doi: 10.36922/td.4178       nodules, highlighting its significant predictive potential. This system can serve as a
            Received: July 9, 2024      valuable adjunct tool for clinicians and imaging physicians in the diagnostic process.
            Accepted: September 2, 2024
                                        Keywords: Artificial intelligence; Pulmonary nodule; Assisted diagnosis
            Published Online: September 25, 2024
            Copyright: © 2024 Author(s).
            This is an Open-Access article
            distributed under the terms of the
            Creative Commons Attribution   1. Introduction
            License, permitting distribution,
            and reproduction in any medium,   Lung cancer exhibits the highest morbidity and mortality rates among malignancies
                                                                                       1
            provided the original work is   worldwide, posing a significant threat to human health.  In 2022, China reported
            properly cited.             approximately 1,060,600 new cases of lung cancer and 733,300 deaths related to the disease,
            Publisher’s Note: AccScience   underscoring its substantial burden on public health. Despite recent advances in lung cancer
            Publishing remains neutral with   treatment technology, about 75% of patients miss the optimal window for treatment due to
            regard to jurisdictional claims in        2
            published maps and institutional   delayed diagnosis.  Early diagnosis and appropriate treatment are essential for improving
            affiliations.               the survival rates of lung cancer patients, particularly through early detection.


            Volume 3 Issue 3 (2024)                         1                                 doi: 10.36922/td.4178
   96   97   98   99   100   101   102   103   104   105   106